| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9901dc75202fcda55737f148fa6aeeca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8eff283948483ae832fd43926ade4a15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea1a3d5adff2da119bc8c0008c8c7351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7194321718cf01e4b6e016119fcc9204 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fca40c1a0e17bc7e95c4c74c2de3282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83f5a71af3b94f01e513c45e0f88b5b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eed47cb23441099c53ffdf5cf1a23864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53f0324c699719384fbde7938bac0fb5 |
| publicationDate |
2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011039646-A2 |
| titleOfInvention |
Papilloma virus -like particles for targeted gene delivery |
| abstract |
Aspects of the invention provide modified virus-like particles for delivery of diagnostic or therapeutic agents. In particular, aspects of the invention provide modified viral capsid proteins that are modified to display targeting peptides when assembled in virus-like particles to direct the virus-like particles to specific sites in vivo. Aspects of the invention further provide methods for treating subjects with one or more modified virus-like particles. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019096796-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10596275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9855347-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110227144-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020385718-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10117947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9700639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9724404-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020154786-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688172-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10300150-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10179168-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10588984-B2 |
| priorityDate |
2009-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |